MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Avanos Medical DIO Ratio 2011-2026 | AVNS
Annual DIO Ratio Avanos Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 180 | 220 | 220 | 158 | 167 | 180 | 170 | 121 | 96.2 | 106 | 92 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 220 | 92 | 155 |
Quarterly DIO Ratio Avanos Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 146 | 155 | 163 | - | 192 | 198 | 210 | - | 184 | 222 | 223 | - | 229 | 215 | 159 | - | 155 | 148 | 169 | - | 171 | 200 | 183 | - | 174 | 181 | 186 | - | 183 | 167 | 148 | - | 120 | 129 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 229 | 120 | 177 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M |  USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
213 | $ 3.92 | -1.51 % | $ 136 M | USA |
 |
Alphatec Holdings
ATEC
|
304 | $ 13.47 | -3.09 % | $ 1.93 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.2 | -6.13 % | $ 517 M |  Israel |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 293.69 | -2.09 % | $ 8.29 B | USA |
 |
Bruker Corporation
BRKR
|
216 | $ 42.43 | 2.04 % | $ 6.32 K | USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
211 | $ 42.33 | - | $ 1.31 B | USA |
 |
Boston Scientific Corporation
BSX
|
184 | $ 73.47 | - | $ 108 B | USA |
 |
Abbott Laboratories
ABT
|
125 | $ 113.59 | - | $ 198 B | USA |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
220 | $ 13.37 | - | $ 361 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.9 | 6.52 % | $ 183 M |  France |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
91.2 | $ 25.26 | - | $ 214 M | USA |
 |
InMode Ltd.
INMD
|
246 | $ 14.24 | -2.6 % | $ 1.13 B | Israel |
 |
IRadimed Corporation
IRMD
|
251 | $ 103.08 | -1.97 % | $ 1.31 B | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.58 | -0.69 % | $ 122 M | USA |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
69.1 | $ 87.18 | 1.2 % | $ 2.93 B | USA |
 |
Globus Medical
GMED
|
266 | $ 88.26 | -0.52 % | $ 12 B | USA |
 |
Pulmonx Corporation
LUNG
|
282 | $ 1.45 | - | $ 56.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 11.18 | 1.82 % | $ 861 M | USA |
 |
Establishment Labs Holdings
ESTA
|
511 | $ 72.72 | 0.19 % | $ 2.05 B |  Costa-rica |
 |
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | Israel |
 |
IRIDEX Corporation
IRIX
|
125 | $ 1.43 | - | $ 23.1 M | USA |
 |
Invacare Corporation
IVC
|
82.8 | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
106 | $ 0.62 | -7.43 % | $ 33.7 M | USA |